Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?
Read Full NewsThese were the most impactful FDA approval stories that were part of our coverage in 2025, brought to you as part of NeurologyLive's Year in Review.
As part of NeurologyLive®'s Year in Review, take a look at our top collaborative interviews with the Strategic Alliance Partnership program in 2025.
1.
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances
2.
Report provides global picture of wide inequalities in care for women's cancers
3.
It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.
4.
Nasal therapeutic HPV vaccine could prevent cervical cancer
5.
Waiting for a Sharp Increase in Prostate Cancer Cases.
1.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
2.
Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective
3.
The Unseen Danger of Anal Cancer: How to Protect Yourself
4.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
5.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge